PWMG
CYTK icon

Private Wealth Management Group’s Cytokinetics CYTK Stock Holding History

Private Wealth Management Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Hold
119
– – ﹤0.01% 575
2026
Q1 		$7.84K Hold
119
– – ﹤0.01% 605
2025
Q4 		$7.56K Hold
119
– – ﹤0.01% 607
2025
Q3 		$6.54K Hold
119
– – ﹤0.01% 684
2025
Q2 		$3.93K Buy
+119
New +$4.14K ﹤0.01% 851

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Management Group's CYTK Position: Q2 2026 in Review

Private Wealth Management Group held its Cytokinetics (CYTK) position steady in Q2 2026 at 119 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Private Wealth Management Group first reported a position in CYTK in Q2 2025 and has held it in 5 quarters since. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Private Wealth Management Group held 119 shares of Cytokinetics worth $10.1K as of Q2 2026.
  • Private Wealth Management Group left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #575 holding.
  • Private Wealth Management Group first reported a position in Cytokinetics in Q2 2025 and has held it in 5 quarters since.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.